Vanc Pharmaceuticals Inc. CEO Arun Nayyar resigned, effective immediately.
Bob Rai replaced Nayyar on an interim basis. Rai, who has been a director at Vanc since June 2015, is chairman and CEO of Canada Pacific Global Pharmaceuticals.
Vanc Pharmaceuticals CEO resigns; interim named
Gauging Supply Chain Risk In Volatile Times
Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals
The Future of Risk Management Digitization in Credit Risk Management
Climate Credit Analytics: Diving into the model
Vanc Pharmaceuticals CEO resigns; interim named
- Author Ayesha Hassan
- Theme Healthcare & Pharmaceuticals